Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A concise, practical guide to diagnostic assessment for mast cell activation disease
Lawrence B. Afrin, Gerhard J. Molderings
World Journal of Hepatology (2014) Vol. 3, Iss. 1, pp. 1-17
Closed Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome
Lawrence B. Afrin, Leonard B. Weinstock, Gerhard J. Molderings
International Journal of Infectious Diseases (2020) Vol. 100, pp. 327-332
Open Access | Times Cited: 283
Mast Cell-Mediated Mechanisms of Nociception
Anupam Aich, Lawrence B. Afrin, Kalpna Gupta
International Journal of Molecular Sciences (2015) Vol. 16, Iss. 12, pp. 29069-29092
Open Access | Times Cited: 139
Recent advances in our understanding of mast cell activation – or should it be mast cell mediator disorders?
Theoharis C. Theoharides, Irene Tsilioni, Huali L. Ren
Expert Review of Clinical Immunology (2019) Vol. 15, Iss. 6, pp. 639-656
Open Access | Times Cited: 101
Diagnosis of mast cell activation syndrome: a global “consensus-2”
Lawrence B. Afrin, Mary B. Ackerley, Linda S. Bluestein, et al.
Diagnosis (2020) Vol. 8, Iss. 2, pp. 137-152
Open Access | Times Cited: 82
Long-Term COVID 19 Sequelae in Adolescents: the Overlap with Orthostatic Intolerance and ME/CFS
Amanda K. Morrow, Laura A. Malone, Christina Kokorelis, et al.
Current Pediatrics Reports (2022) Vol. 10, Iss. 2, pp. 31-44
Open Access | Times Cited: 52
Association of postural orthostatic tachycardia syndrome, hypermobility spectrum disorders, and mast cell activation syndrome in young patients; prevalence, overlap and response to therapy depends on the definition
Lilian Yao, K.G. Subramaniam, Katherine Raja, et al.
Frontiers in Neurology (2025) Vol. 16
Open Access | Times Cited: 1
Characterization of Mast Cell Activation Syndrome
Lawrence B. Afrin, Sally Self, Jeremiah Menk, et al.
The American Journal of the Medical Sciences (2016) Vol. 353, Iss. 3, pp. 207-215
Open Access | Times Cited: 83
Often seen, rarely recognized: mast cell activation disease – a guide to diagnosis and therapeutic options
Lawrence B. Afrin, Joseph H. Butterfield, Martin Raithel, et al.
Annals of Medicine (2016) Vol. 48, Iss. 3, pp. 190-201
Closed Access | Times Cited: 65
Pharmacological treatment options for mast cell activation disease
Gerhard J. Molderings, Britta Haenisch, Stefan Brettner, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2016) Vol. 389, Iss. 7, pp. 671-694
Open Access | Times Cited: 62
The genetic basis of mast cell activation disease - looking through a glass darkly
Gerhard J. Molderings
Critical Reviews in Oncology/Hematology (2014) Vol. 93, Iss. 2, pp. 75-89
Closed Access | Times Cited: 49
Mast cell activation disease: An underappreciated cause of neurologic and psychiatric symptoms and diseases
Lawrence B. Afrin, Dieter Pöhlau, Martin Raithel, et al.
Brain Behavior and Immunity (2015) Vol. 50, pp. 314-321
Closed Access | Times Cited: 43
Mast cell activation disease and the modern epidemic of chronic inflammatory disease
Lawrence B. Afrin
Translational research (2016) Vol. 174, pp. 33-59
Closed Access | Times Cited: 33
Mast cell activation may explain many cases of chemical intolerance
Claudia S. Miller, Raymond F. Palmer, Tania T. Dempsey, et al.
Environmental Sciences Europe (2021) Vol. 33, Iss. 1
Open Access | Times Cited: 24
Determination of Plasma Heparin Level Improves Identification of Systemic Mast Cell Activation Disease
Milda Vysniauskaite, H.-J. Hertfelder, Johannes Oldenburg, et al.
PLoS ONE (2015) Vol. 10, Iss. 4, pp. e0124912-e0124912
Open Access | Times Cited: 31
Transgenerational transmission of systemic mast cell activation disease—genetic and epigenetic features
Gerhard J. Molderings
Translational research (2016) Vol. 174, pp. 86-97
Closed Access | Times Cited: 25
Mast Cell Activation Disease and Microbiotic Interactions
Lawrence B. Afrin, Alexander Khoruts
Clinical Therapeutics (2015) Vol. 37, Iss. 5, pp. 941-953
Closed Access | Times Cited: 23
Mast Cell Activation Syndrome as a Significant Comorbidity in Sickle Cell Disease
Lawrence B. Afrin
The American Journal of the Medical Sciences (2014) Vol. 348, Iss. 6, pp. 460-464
Open Access | Times Cited: 18
Successful mast-cell-targeted treatment of chronic dyspareunia, vaginitis, and dysfunctional uterine bleeding
Lawrence B. Afrin, Tania T. Dempsey, Lila S. Rosenthal, et al.
Journal of Obstetrics and Gynaecology (2019) Vol. 39, Iss. 5, pp. 664-669
Closed Access | Times Cited: 16
Creating a data dictionary for pediatric autonomic disorders
Jeffrey R. Boris, Hasan I. Abdallah, Shelley Ahrens, et al.
Clinical Autonomic Research (2023) Vol. 33, Iss. 3, pp. 301-377
Open Access | Times Cited: 5
Mast cell activation syndrome.
Vicki Ratner
PubMed (2015) Vol. 4, Iss. 5, pp. 587-8
Closed Access | Times Cited: 12
Mast cell activation syndrome in pregnancy, delivery, postpartum and lactation: a narrative review
Shanda R. Dorff, Lawrence B. Afrin
Journal of Obstetrics and Gynaecology (2020) Vol. 40, Iss. 7, pp. 889-901
Closed Access | Times Cited: 9
Mast Cell Biology and Linkages for Non-clonal Mast Cell Activation and Autoimmune/Inflammatory Syndrome Induced by Adjuvants
Nevio Cimolai
SN Comprehensive Clinical Medicine (2020) Vol. 2, Iss. 11, pp. 2310-2323
Closed Access | Times Cited: 9
THE PRESENTATION, DIAGNOSIS AND TREATMENT OF MAST CELL ACTIVATION SYNDROME
Lawrence B. Afrin
(2014)
Closed Access | Times Cited: 5
Chirurgische Eingriffe bei Patienten mit systemischer Mastzellaktivierungserkrankung
Bernd Sido, Jürgen Homann, H.-J. Hertfelder, et al.
Der Chirurg (2019) Vol. 90, Iss. 7, pp. 548-556
Closed Access | Times Cited: 4
Does cystoscopy method affect the investigation of bladder pain syndrome/interstitial cystitis?
Visha Tailor, Ellen Morris, Alka Bhide, et al.
International Urogynecology Journal (2020) Vol. 32, Iss. 5, pp. 1229-1235
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top